CVS - CVS Health Corp
This page shows which of the focused investors we track hold CVS and how their positions changed, so you can see how much conviction the group has in the stock.
In Q3 2018 it was held by 8 managers with an aggregate reported value of $2.81B, which is 0.30% of the combined portfolio.
As of Q3 2018, 8 tracked institutional managers held CVS (CVS Health Corp) with an aggregate reported value of $2.81B — 0.30% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades CVS — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q3 2018
- Ticker
- CVS
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Dodge & Cox - Dodge & Cox | 0.92% | New | 15,125,686 | $1.19B |
| 2 | Bill Nygren - Oakmark Funds | 1.62% | Reduce -2.7% | 13,124,944 | $1.03B |
| 3 | Vulcan Value Partners - Vulcan Value Partners | 3.34% | Reduce -39.0% | 5,811,079 | $457.45M |
| 4 | Richard Pzena - Pzena Investment Management | 0.28% | Reduce -0.5% | 719,080 | $56.61M |
| 5 | Leon Cooperman - Leon Cooperman | 1.34% | Reduce -3.0% | 394,600 | $31.06M |
| 6 | Thomas Gayner - Markel Asset Management | 0.37% | - | 275,000 | $21.65M |
| 7 | David Katz - Matrix Asset Advisors | 1.91% | Reduce -5.5% | 152,088 | $11.97M |
| 8 | Robert Olstein - Olstein Capital Management | 1.35% | Reduce -21.9% | 128,000 | $10.08M |
Loading holder history for CVS…